N-((S)-1-((S)-1-((S)-2-((tert-butyldimethylsilyloxy)methyl)oxiran-2-yl)-4-methyl-1-oxopentan-2-ylamino)-1-oxopropan-2-yl)heptanamide N-((S)-1-((S)-1-((S)-2-((tert-butyldimethylsilyloxy)methyl)oxiran-2-yl)-4-methyl-1-oxopentan-2-ylamino)-1-oxopropan-2-yl)heptanamide

CAS 1000313-40-5 MFCD100313405

化学结构图

1000313-40-5
SMILES:

别名和识别编码

Chemical Name TranslationN-((S)-1-((S)-1-((S)-2-((tert-butyldimethylsilyloxy)methyl)oxiran-2-yl)-4-methyl-1-oxopentan-2-ylamino)-1-oxopropan-2-yl)heptanamide
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Wehenkel M, et al. A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer. 2012 Jun 26;107(1):53-62.
  • [1]. de Bruin G, et al. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. J Med Chem. 2014 Jul 24;57(14):6197-209.
  • [1]. de Bruin G, et al. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. J Med Chem. 2014 Jul 24;57(14):6197-209.
  • [2]. Wehenkel M, et al. A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer. 2012 Jun 26;107(1):53-62.

系列性分类

  1. Medical Research Areas
  2. Metabolism
  3. Proteasome  (蛋白酶体)

相关产品推荐